{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:29:01Z","timestamp":1788186541817,"version":"build-2803163510"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is the second most common neurodegenerative disease. The main symptoms are motor signs such as resting tremor and difficulty in initializing movements. Non-motor alterations, such as cognitive deficits, can precede the motor symptoms. PD is more frequent in men than women. The mechanisms related to this difference are not completely understood. There is evidence that females present distinct characteristics in dopaminergic function compared to males. While the severity of motor impairments is often compared between sexes, little is known about sex differences in the prodromal stage. Most animal models of PD present acute severe motor impairment, which precludes the study of non-motor symptoms. Our research group have proposed an adaptation of the classic reserpine protocol, using low doses in a chronic treatment. This method allows the observation of progressive motor impairment as well as premotor deficits. Here we investigate possible behavioral and neuronal sex differences in the effects of the repeated treatment with a low dose of reserpine in rats. Male and female Wistar rats received 10\u201315 injections of reserpine (0.1 mg\/kg) or vehicle, on alternate days. We followed-up the estrous cycle phases and conducted motor and cognitive assessments (catalepsy, open field, oral movements and object recognition tests). The euthanasia occurred 48 h after the 10th or 15th injections, with the collection of blood for the quantification of sex hormones and brains for tyrosine hydroxylase (TH) immunohistochemistry in the substantia nigra pars compact (SNpc). Reserpine induced progressive catalepsy, involuntary oral movements and cognitive deficits in male rats. The behavioral effects of reserpine were attenuated (motor) or absent (cognitive) in females. Reserpine decreased TH immunoreactivity in males, but not in females. Estrogen levels in females negatively correlated with catalepsy duration. Our findings show that females present a delay and\/or a prevention in the reserpine-induced motor alterations in the progressive PD model, compatible with the lower prevalence of this disease in women. Further, females were protected from the deficit in object recognition at the prodromal stage. The absence of reserpine-induce decrease in TH immunoreactivity suggests that differences in dopaminergic function\/plasticity are related to this protection in female sex.<\/jats:p>","DOI":"10.3389\/fnagi.2021.757714","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T02:17:20Z","timestamp":1635128240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson\u2019s Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Alvaro C.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ywlliane S. R.","family":"Meurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicius S.","family":"Bioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora M. G.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narriman","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo B.","family":"Lopes-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Becegato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela B. L.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela F.","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina H.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0278-5846(02)00340-8","article-title":"Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione\/reduced glutathione ratio (GSSG\/GSH) enhancement in rats.","volume":"27","author":"Ab\u00edlio","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder.","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialog. Clin. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.pbb.2010.03.009","article-title":"Sex differences in motor behavior in the MPTP mouse model of Parkinson\u2019s disease.","volume":"95","author":"Antzoulatos","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/syn.890050211","article-title":"Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release.","volume":"5","author":"Becker","year":"1990","journal-title":"Synapse"},{"key":"B5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1006\/bbrc.1995.2647","article-title":"17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro.","volume":"216","author":"Behl","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/mds.1170","article-title":"Hysterectomy, menopause, and estrogen use preceding Parkinson\u2019s disease: an exploratory case-control study.","volume":"16","author":"Benedetti","year":"2001","journal-title":"Mov. Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbr.2019.01.041","article-title":"Sex differences in the progressive model of parkinsonism induced by reserpine in rats.","volume":"363","author":"Bispo","year":"2019","journal-title":"Behav. Brain Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0166-2236(90)90058-i","article-title":"Cognitive function in Parkinson\u2019s disease: from description to theory.","volume":"13","author":"Brown","year":"1990","journal-title":"Trends Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbr.2017.04.028","article-title":"Exposure to an enriched environment facilitates motor recovery and prevents short-term memory impairment and reduction of striatal BDNF in a progressive pharmacological model of parkinsonism in mice.","volume":"328","author":"Campelo","year":"2017","journal-title":"Behav. Brain Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.brainres.2004.12.009","article-title":"Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson\u2019s disease.","volume":"1034","author":"Cass","year":"2005","journal-title":"Brain Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.parkreldis.2016.02.024","article-title":"Dementia in Parkinson\u2019s disease: is male gender a risk factor?","volume":"26","author":"Cereda","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00415-008-5006-1","article-title":"Early Parkinson\u2019s disease and non-motor issues.","author":"Chaudhuri","year":"2008","journal-title":"J. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment.","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0149-7634(01)00011-2","article-title":"A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field.","volume":"25","author":"Choleris","year":"2001","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2021.03.001","article-title":"Nociception alterations precede motor symptoms in a progressive model of parkinsonism induced by reserpine in middle-aged rats.","volume":"171","author":"Cintra","year":"2021","journal-title":"Brain Res. Bull."},{"key":"B16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.biopsych.2007.03.001","article-title":"Evolving knowledge of sex differences in brain structure, function, and chemistry.","volume":"62","author":"Cosgrove","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/0091-3057(85)90544-1","article-title":"Effects of chronically administered nicotine and saline on motor activity in rats.","volume":"22","author":"Cronan","year":"1985","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00001756-200301200-00009","article-title":"Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle.","volume":"14","author":"Datla","year":"2003","journal-title":"Neuroreport"},{"key":"B19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1385\/endo:21:1:67","article-title":"Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.","volume":"21","author":"Dluzen","year":"2003","journal-title":"Endocrine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1023\/a:1007117424491","article-title":"Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system.","volume":"29","author":"Dluzen","year":"2000","journal-title":"J. Neurocytol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1046\/j.1471-4159.1996.66020658.x","article-title":"Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release.","volume":"66","author":"Dluzen","year":"1996","journal-title":"J. Neurochem."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111198","article-title":"Balance alterations and reduction of pedunculopontine cholinergic neurons in early stages of parkinsonism in middle-aged rats.","volume":"145","author":"Dos Santos","year":"2021","journal-title":"Exp. Gerontol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbr.2012.03.008","article-title":"Repeated treatment with a low dose of reserpine as a progressive model of Parkinson\u2019s disease.","volume":"231","author":"Fernandes","year":"2012","journal-title":"Behav. Brain Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbr.2006.07.004","article-title":"Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson\u2019s disease.","volume":"174","author":"Field","year":"2006","journal-title":"Behav. Brain Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1021\/tx600325u","article-title":"Inhibition of VMAT-2 and DT-diaphorase induce cell death in a substantia nigra-derived cell line\u2013an experimental cell model for dopamine toxicity studies.","volume":"20","author":"Fuentes","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.pbb.2004.04.022","article-title":"Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson\u2019s disease.","volume":"78","author":"Gillies","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.yfrne.2014.02.002","article-title":"Sex differences in Parkinson\u2019s disease.","volume":"35","author":"Gillies","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","article-title":"Gender differences in Parkinson\u2019s disease.","volume":"78","author":"Haaxma","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brainresbull.2017.05.015","article-title":"Ceftriaxone reverses deficits of behavior and neurogenesis in an MPTP-induced rat model of Parkinson\u2019s disease dementia.","volume":"132","author":"Hsieh","year":"2017","journal-title":"Brain Res. Bull."},{"key":"B32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/350230a0","article-title":"BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.","volume":"350","author":"Hyman","year":"1991","journal-title":"Nature"},{"key":"B33","first-page":"555","article-title":"Repeated treatment with a low dose of reserpine as a progressive model of Parkinson\u2019s dementia.","volume":"32","author":"Ikram","year":"2019","journal-title":"Pak. J. Pharm. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.brainresbull.2019.01.009","article-title":"Cognitive and anxiety-like impairments accompanied by serotonergic ultrastructural and immunohistochemical alterations in early stages of parkinsonism.","volume":"146","author":"Leal","year":"2019","journal-title":"Brain Res. Bull."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113349","article-title":"Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously hypertensive rats (SHR): implications for cognitive deficits in a progressive animal model for Parkinson\u2019s disease.","volume":"410","author":"Le\u00e3o","year":"2021","journal-title":"Behav Brain Res."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00078","article-title":"Spontaneously hypertensive rats (SHR) are resistant to a reserpine-induced progressive model of Parkinson\u2019s disease: differences in motor behavior, tyrosine hydroxylase and alpha-synuclein expression.","volume":"9","author":"Le\u00e3o","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/bpa.12253","article-title":"Molecular, neurochemical, and behavioral hallmarks of reserpine as a model for Parkinson\u2019s disease: new perspectives to a long-standing model.","volume":"25","author":"Le\u00e3o","year":"2015","journal-title":"Brain Pathol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainresbull.2018.01.017","article-title":"Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine.","volume":"139","author":"Lins","year":"2018","journal-title":"Brain Res. Bull."},{"key":"B39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev.physiol.66.032802.154945","article-title":"Estrogens in the nervous system: mechanisms and nonreproductive functions.","volume":"66","author":"Maggi","year":"2004","journal-title":"Annu. Rev. Physiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1590\/s1519-69842002000400008","article-title":"Determination of the estrous cycle phases of rats: some helpful considerations.","volume":"62","author":"Marcondes","year":"2002","journal-title":"Braz. J. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00415-011-6392-3","article-title":"Gender-related differences in the burden of non-motor symptoms in Parkinson\u2019s disease.","volume":"259","author":"Martinez-Martin","year":"2012","journal-title":"J. Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bbr.2015.12.011","article-title":"Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats.","volume":"301","author":"Matheus","year":"2016","journal-title":"Behav. Brain Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1471-4159.2006.04226.x","article-title":"Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.","volume":"100","author":"McArthur","year":"2007","journal-title":"J. Neurochem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mce.2008.04.008","article-title":"Estrogen and SERM neuroprotection in animal models of Parkinson\u2019s disease.","volume":"290","author":"Morissette","year":"2008","journal-title":"Mol. Cell Endocrinol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","article-title":"Motor symptoms in Parkinson\u2019s disease: a unified framework.","volume":"68","author":"Moustafa","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0306-4522(02)00578-x","article-title":"Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.","volume":"116","author":"Murray","year":"2003","journal-title":"Neuroscience"},{"key":"B48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mce.2009.07.011","article-title":"Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL\/6 mice.","volume":"311","author":"Ookubo","year":"2009","journal-title":"Mol. Cell Endocrinol."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00343","article-title":"Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats.","volume":"7","author":"Peres","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2018.10.006","article-title":"Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: a systematic review and meta-analysis.","volume":"1704","author":"Rahmani","year":"2019","journal-title":"Brain Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1523\/JNEUROSCI.0313-19.2019","article-title":"Female sex and brain-selective estrogen benefit alpha-synuclein tetramerization and the PD-like motor syndrome in 3K transgenic mice.","volume":"39","author":"Rajsombath","year":"2019","journal-title":"J. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pbb.2013.01.001","article-title":"Gallic acid decreases vacuous chewing movements induced by reserpine in rats.","volume":"104","author":"Reckziegel","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-020-0109-1","article-title":"Sex specific cognitive differences in Parkinson disease.","volume":"6","author":"Reekes","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bandc.2010.07.012","article-title":"Sex differences in aversive memory in rats: possible role of extinction and reactive emotional factors.","volume":"74","author":"Ribeiro","year":"2010","journal-title":"Brain Cogn."},{"key":"B55","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/JPD-181306","article-title":"Progression of cognitive decline in Parkinson\u2019s disease.","volume":"8","author":"Roheger","year":"2018","journal-title":"J. Parkinsons Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1037\/\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs.","volume":"102","author":"Sanberg","year":"1988","journal-title":"Behav. Neurosci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbr.2013.06.031","article-title":"Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine.","volume":"253","author":"Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1212\/wnl.52.7.1417","article-title":"The effect of estrogen replacement on early Parkinson\u2019s disease.","volume":"52","author":"Saunders-Pullman","year":"1999","journal-title":"Neurology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1034\/j.1600-0404.2000.102001037.x","article-title":"Gender differences in Parkinson\u2019s disease symptom profile.","volume":"102","author":"Scott","year":"2000","journal-title":"Acta Neurol. Scand."},{"key":"B60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1550-8579(07)80003-9","article-title":"Gender differences in Parkinson\u2019s disease.","volume":"4","author":"Shulman","year":"2007","journal-title":"Gender Med."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00306","article-title":"Influence of estrogen modulation on glia activation in a murine model of Parkinson\u2019s disease.","volume":"11","author":"Siani","year":"2017","journal-title":"Front. Neurosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s0166-4328(01)00409-0","article-title":"Concomitant development of oral dyskinesia and memory deficits in reserpine-treated male and female mice.","volume":"132","author":"Silva","year":"2002","journal-title":"Behav. Brain Res."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13563","article-title":"Myrtenol complexed with \u03b2-cyclodextrin ameliorates behavioural deficits and reduces oxidative stress in the reserpine-induced animal model of Parkinsonism.","author":"Silva-Martins","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1093\/geronb\/63.1.s42","article-title":"Sex and gender in older adults\u2019 experience of Parkinson\u2019s disease.","volume":"63","author":"Solimeo","year":"2008","journal-title":"J. Gerontol. B Psychol. Sci. Soc. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bbr.2004.09.002","article-title":"Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats.","volume":"158","author":"Tamas","year":"2005","journal-title":"Behav. Brain Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.steroids.2017.12.010","article-title":"Sex-related differences in oxidative stress and neurodegeneration.","volume":"133","author":"Tenkorang","year":"2018","journal-title":"Steroids"},{"key":"B67","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1590\/S0482-50042011000500006","article-title":"Prolactin, estradiol and anticardiolipin antibodies in premenopausal women with systemic lupus erythematosus: a pilot study.","volume":"51","author":"Tiskievicz","year":"2011","journal-title":"Rev. Bras. Reumatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/practneurol-2013-000741","article-title":"Non-motor Parkinson\u2019s: integral to motor Parkinson\u2019s, yet often neglected.","volume":"14","author":"Todorova","year":"2014","journal-title":"Pract. Neurol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1212\/wnl.54.12.2292","article-title":"Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations.","volume":"54","author":"Tsang","year":"2000","journal-title":"Neurology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity.","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22074\/cellj.2019.5799","article-title":"17 \u03b2-estradiol oxidative stress attenuation and autophagy-induced dopaminergic neuroprotection.","volume":"21","author":"Varmazyar","year":"2019","journal-title":"Cell J."},{"key":"B73","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1037\/0033-2909.83.3.482","article-title":"The open-field test: a critical review.","volume":"83","author":"Walsh","year":"1976","journal-title":"Psychol. Bull."},{"key":"B74","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.05.023","article-title":"Low BDNF is associated with cognitive impairments in patients with Parkinson\u2019s disease.","volume":"29","author":"Wang","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1186\/1750-2187-1-5","article-title":"Estradiol effects on the dopamine transporter - protein levels, subcellular location, and function.","volume":"1","author":"Watson","year":"2006","journal-title":"J. Mol. Signal."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson\u2019s disease: a review of the evidence.","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur. J. Epidemiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s007020070084","article-title":"Sexual differences and estrous cycle in methamphetamine-induced dopamine and serotonin depletions in the striatum of mice.","volume":"107","author":"Yu","year":"2000","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B78","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/jnc.15282","article-title":"Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-\u03b2-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons.","volume":"157","author":"Zarate","year":"2021","journal-title":"J. Neurochem"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.757714\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T02:17:27Z","timestamp":1635128247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.757714\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":76,"alternative-id":["10.3389\/fnagi.2021.757714"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2021.757714","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"article-number":"757714"}}